Option Iceman 6:37 am on Monday, December 12, 2016

$OPHT – from $40 to…

$OPHT – from $40 to $6 – why I’m not a fan of biotech stocks

Option Iceman 9:37 am on Monday, December 12, 2016

$REGN – Fortunately for Regeneron Pharmaceuticals investors, Opthotech’s failure eliminates a potential threat to Regeneron’s Eylea wet AMD market. Shares of Regeneron are up 5 percent on Monday.
- fuzzballl 10:06 am on Monday, December 12, 2016
  
  Hopefully @scottto wasn’t holding 10 thousand shares of OPHT. He pounded the table long and hard about it being the next REGN…

Leave a Reply Cancel reply

s: search
c: compose new post
r: reply
e: edit
t: go to top
j: go to the next post or comment
k: go to the previous post or comment
o: toggle comment visibility
esc: cancel edit post or comment